SUPPLIES FOR IN SITU HYBRIDIZATION (ISH) TECHNIQUE AND OTHERS

This tender, issued by the HOSPITAL ORIENTE DR LUIS TISNE BROUSSE, seeks the supply of essential materials for performing the In Situ Hybridization (ISH) technique. The procurement is specifically for reagents and hybridization buffer solutions required for optical microscopy applications. The scope includes supplies for diagnostic algorithms, validated for the HER2 gene and Centromere 17, intended for use with automated equipment provided on a loan basis (comodato). The required items fall under the category of laboratory equipment, specifically laboratory equipment and supplies, and laboratory electrophoresis and transfer systems and supplies. The tender specifies a quantity of one unit for this comprehensive supply package. The procurement is located within the Metropolitan Region of Santiago, Chile. This acquisition is crucial for the hospital's diagnostic capabilities, particularly in areas requiring molecular pathology analysis. The successful bidder will be responsible for providing high-quality, validated reagents and solutions that are compatible with automated ISH platforms, ensuring accurate and reliable diagnostic results for patients. The emphasis on validated algorithms and automated equipment suggests a need for advanced, state-of-the-art laboratory consumables that meet stringent performance standards.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Hospitals and Laboratory. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.